Symyx Technologies

Last updated

Symyx Technologies
IndustryLife Sciences; Chemical and Energy and Performance; Materials and Consumer Products
Successor
  • Spinoff: Freestate, Inc.
  • Merged: Accelrys
Founded1994;27 years ago (1994)
Headquarters Santa Clara, CA United States
Key people
 Isy Goldwasser, CEO
Steven D. Goldby, Executive Chairman
Rex S. Jackson, Executive Vice President and General Counsel
W. Henry Weinberg PhD, Executive Vice President and CTO
Luigi Berini CEO of Symyx Technologies Europe
ProductsElectronic lab notebook and R&D execution and analysis software, lab automation and breakthrough materials technology
Number of employees
400
Website accelrys.com//

Symyx Technologies, Inc. was a company that specialized in informatics and automation products. Symyx provided software solutions for scientific research, including Enterprise Laboratory Notebooks and products for combinatorial chemistry. The software part of the business became part of Accelrys, Inc. in 2010 and then in 2014 this company merged with Dassault Systèmes. Symyx also offered laboratory robotics systems for performing automated chemical research, which in 2010 was spun out as Freeslate, Inc.

Contents

Products

Symyx offered high-speed combinatorial technologies for the discovery of new materials. Using proprietary technologies - including instruments, software and methods - Symyx was able to generate hundreds to thousands of unique materials at a time and screen those materials rapidly and automatically for desired properties. This approach was said to deliver results hundreds to thousands of times faster than traditional research methods, at a fraction of the cost. [1] Symyx applied this technology to revolutionize materials discovery in the life sciences, chemical, and electronics industries.

History

Founded in 1994 by Dr. Alejandro Zaffaroni and Dr. Peter G. Schultz, Symyx' conceptual basis drew from Affymax, Inc. and Affymetrix, Inc., which commercialized the use of high-speed combinatorial methods for pharmaceutical and genetic research, respectively. [2] Dr. Eric McFarland, professor at UCSB, was the founding director. [3] [4] Symyx screens about a million materials a year and has produced a product pipeline with several materials that have the potential to be commercialized in the next few years. Examples of their discovery efforts include X-ray storage phosphors for radiography, polymers to speed DNA research and catalysts for the manufacture of pharmaceuticals, chemicals and plastics.

In 2004, Symyx Technologies acquired Intellichem, a software manufacturer for electronic laboratory notebooks [5] [6] and, in 2007 Symyx Technologies acquired MDL Information Systems (originally Molecular Design Limited, Inc.), a provider of R&D informatics in the chemistry and life sciences industries, which had been launched as a computer-aided drug design firm in January 1978. With this purchase came the purveyorship of the Centers for Disease Control and Prevention-NIOSH Registry of Toxic Effects of Chemical Substances (RTECS, www.cdc.gov/niosh/rtecs), a database of basic toxicity information on household chemical substances, food additives, drugs, solvents, biocides, and chemical waste components which as of first quarter of 2012 contained ≈170,000 entries. In 2008, Symyx sold non-RTECS portions of the occupational health and safety (OHS) component of the MDL business to ChemAdvisor, Inc., of Pittsburgh, Pennsylvania. Subsequent innovations derived from these business components included an enterprise electronic laboratory notebook (ELN) capable of supporting multiple scientific disciplines. [7]

In 2010 Symyx spun off their laboratory robotics business as Freeslate, Inc. Freeslate developed high throughput systems for automating chemical research. In 2010, the remaining Symyx software business merged with Accelrys, with the combined company being known simply as Accelrys. [8] [9] In 2014, Accelrys in turn merged with Dassault Systèmes, [10] who announced the creation of the BIOVIA brand to supply software for scientific applications. [11]

Business model considerations

The concept of combinatory chemistry (outside of bio-tech area) was the focus of Symyx. The initial Symyx business model was to provide contract research for large chemical companies at a contract size from $0.5 Million to $200 Million. The company had initial success in gaining enough contracts to reach profitability, with small deals with few initial customers which led to large deals, such as with Exxon. Symyx then started to sell equipment.

One other key point was the company had to develop new tools and hire new people when a new project came up because the contract was in a brand new research area and required different expertise. Therefore, the research contract business was not scalable. This is seen as the reason for company failure, even though the company had over 500 patents. Other companies followed Symyx's path. Intermolecular licensed Symyx patents on electronic materials and is developing tools for the electronic materials companies.

Related Research Articles

Dassault Systèmes SE is a French software corporation. It is among Fortune 50 list of the largest software companies that develops software for 3D product design, simulation, manufacturing and more.

Chemical table file is a family of text-based chemical file formats that describe molecules and chemical reactions. One format, for example, lists each atom in a molecule, the x-y-z coordinates of that atom, and the bonds among the atoms.

Registry of Toxic Effects of Chemical Substances (RTECS) is a database of toxicity information compiled from the open scientific literature without reference to the validity or usefulness of the studies reported. Until 2001 it was maintained by US National Institute for Occupational Safety and Health (NIOSH) as a freely available publication. It is now maintained by the private company BIOVIA or from several value-added resellers and is available only for a fee or by subscription.

Bruce Pasternack was the President and CEO of the Special Olympics International from 2005-2007. He served on the board of directors of Codexis, a biotechnology company based out of Redwood City California, Accelrys, Inc. a software company specializing in biotechnology, BEA Systems a company specialized in enterprise infrastructure software products, Quantum Corporation a manufacturer of data storage devices and systems, and Symyx Technologies a company that specialized in informatics and automation products. Prior to being a director for public companies, he was a Senior Vice President of Booz-Allen & Hamilton Inc. for over 20 years, and the Managing Partner of the firm's organization and strategic leadership center and its offices in California as well as leading the energy, chemicals and pharmaceuticals practice.

CASTEP is a shared-source academic and commercial software package which uses density functional theory with a plane wave basis set to calculate the electronic properties of crystalline solids, surfaces, molecules, liquids and amorphous materials from first principles. CASTEP permits geometry optimisation and finite temperature molecular dynamics with implicit symmetry and geometry constraints, as well as calculation of a wide variety of derived properties of the electronic configuration. Although CASTEP was originally a serial, Fortran 77-based program, it was completely redesigned and rewritten from 1999 to 2001 using Fortran 95 and MPI for use on parallel computers by researchers at the Universities of York, Durham, St. Andrews, Cambridge and Rutherford Labs.

MDL Information Systems, Inc. was a provider of R&D informatics products for the life sciences and chemicals industries. The company was launched as a computer-aided drug design firm in January 1978 in Hayward, California. The company was acquired by Symyx Technologies, Inc. in 2007. Subsequently Accelrys merged with Symyx. The Accelrys name was retained for the combined company. In 2014 Accelrys was acquired by Dassault Systemes. The Accelrys business unit was renamed BioVia.

ISIS/Draw

ISIS/Draw was a chemical structure drawing program developed by MDL Information Systems. It introduced a number of file formats for the storage of chemical information that have become industry standards.

BIOVIA is a software company headquartered in the United States, with representation in Europe and Asia. It provides software for chemical, materials and bioscience research for the pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries.

Bernard Charlès is a French business executive. He is the chief executive officer and the vice-chairman of the board of directors of Dassault Systèmes, "the 3DEXPERIENCE Company", world leader in 3D design software, 3D digital mock-up and Product Lifecycle Management (PLM) solutions. Charlès is the 13th best-performing CEO in the world according to the Harvard Business Review 2017 ranking. In 2018 Dassault Systèmes was named the most sustainable corporation in the world in the Global 100 Most Sustainable Corporations in the World index by Corporate Knights. In 2018, he was named one of the "Best CEOs In The World" by the CEOWORLD magazine.

Materials Studio is software for simulating and modeling materials. It is developed and distributed by BIOVIA, a firm specializing in research software for computational chemistry, bioinformatics, cheminformatics, molecular dynamics simulation, and quantum mechanics.

Department of Materials Science and Metallurgy, University of Cambridge

The Department of Materials Science and Metallurgy (DMSM) is a large research and teaching division of the University of Cambridge. Since 2013 it has been located in West Cambridge, having previously occupied several buildings on the New Museums Site in the centre of Cambridge.

Graham Richards

(William) Graham Richards is a chemist and Emeritus Fellow of Brasenose College, Oxford. He served as head of the department of chemistry at the University of Oxford from 1997 to 2006.

Tom Baruch is an American businessman and venture capitalist (VC) based out of San Francisco, California. He was a founding partner of the VC funds CMEA Capital, Formation 8 and is now the Managing Director of his family office: Baruch Future Ventures (BFV).

Dotmatics is a scientific informatics company, focusing on data management, analysis and visualization. Founded in 2005, the company's headquarters are in Bishops Stortford, Hertfordshire, England and has two US offices in San Diego, CA and Woburn, MA. Dotmatics provides software to half of the world's 20 largest drugmakers.

Pipeline Pilot is a desktop software program sold by Dassault Systèmes for processing and analyzing data. Originally used in the natural sciences, the product's basic ETL and analytics capabilities have been broadened. The product is now used for data science, ETL, reporting, prediction and analytics in a number of sectors. The main feature of the product is the ability to design data workflows using a graphical user interface. The program is an example of visual and dataflow programming. It has use in a variety of settings, such as cheminformatics and QSAR, Next Generation Sequencing, image analysis, and text analytics.

Mettler Toledo

Mettler Toledo is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory, industrial, and food retailing applications. The company also provides various analytical instruments, process analytics instruments, and end-of-line inspection systems. The company operates worldwide with 70% of net sales, derived in equal parts, from Europe and from the Americas. Asian business is included in the remaining 30%. Mettler Toledo is headquartered in Switzerland and incorporated in the United States.

Tokuyama Corporation is a Japanese, Tokyo-based chemical company and the world's fourth largest silicon manufacturer.

Stephen L. Mayo

Stephen L. Mayo is a professor at the California Institute of Technology, where he is the William K. Bowes Jr. Leadership Chair in the Division of Biology and Biological Engineering, and the Bren Professor of Biology and Chemistry. His research focuses on structural biology and the development of computational methods for protein design. Mayo was elected to the United States National Academy of Sciences in 2004 and was appointed to a six-year term on the National Science Board in 2013.

References

  1. ↑ "Symyx Technologies & Pharmaceutical R&D: A Synergistic Combo". July 2007. Archived from the original on 28 September 2007.
  2. ↑ "Automated Research: Not just for pharma". April 2007. Archived from the original on 29 September 2007.
  3. ↑ "Eric McFarland". 22 July 2015.
  4. ↑ "Eric W. McFarland, PhD, M.D. | Greenyug LLC".
  5. ↑ "Symyx buying IntelliChem". bizjournals.com. 15 November 2004. Retrieved 17 September 2015.
  6. ↑ Van Eikeren, Paul (2004). "Intelligent Electronic Laboratory Notebooks for Accelerated Organic Process R&D". Organic Process Research & Development. 8 (6): 1015–1023. doi:10.1021/op049890j.
  7. ↑ Symyx Notebook, 2008 Archived 28 September 2011 at the Wayback Machine
  8. ↑ Allen, Mike (2 July 2010). "Shareholders approve Accelrys-Symyx merger". San Diego Business Journal. Retrieved 3 December 2010.
  9. ↑ "Accelrys and Symyx merger announcement (from genomeweb)". April 2010.
  10. ↑ "Dassault Systèmes and Accelrys to merge PLM & chemistry". 30 January 2014. Retrieved 14 June 2020.
  11. ↑ "Dassault Systèmes Introduces BIOVIA". 21 May 2014. Retrieved 14 June 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.